184 related articles for article (PubMed ID: 32017579)
1.
Hijazi K; Iannelli F; Cuppone AM; Desjardins D; Caldwell A; Dereuddre-Bosquet N; Scala C; Smith KA; Mukhopadya I; Frank B; Gwozdz G; Santoro F; Grand RL; Pozzi G; Kelly C
Mol Pharm; 2020 Mar; 17(3):852-864. PubMed ID: 32017579
[TBL] [Abstract][Full Text] [Related]
2. Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs.
Hijazi K; Cuppone AM; Smith K; Stincarelli MA; Ekeruche-Makinde J; De Falco G; Hold GL; Shattock R; Kelly CG; Pozzi G; Iannelli F
PLoS One; 2015; 10(6):e0131405. PubMed ID: 26102284
[TBL] [Abstract][Full Text] [Related]
3. Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.
Zhou T; Hu M; Pearlman A; Rohan LC
Biochem Pharmacol; 2016 Sep; 116():162-75. PubMed ID: 27453435
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
[TBL] [Abstract][Full Text] [Related]
5. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques.
Dobard CW; Sharma S; Cong ME; West R; Makarova N; Holder A; Pau CP; Hanson DL; Novembre FJ; Garcia-Lerma JG; Heneine W
Retrovirology; 2015 Aug; 12():69. PubMed ID: 26253002
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa
Carserides C; Smith K; Zinicola M; Kumar A; Swedrowska M; Scala C; Cameron G; Riches Z; Iannelli F; Pozzi G; Hold GL; Forbes B; Kelly C; Hijazi K
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145684
[TBL] [Abstract][Full Text] [Related]
8. Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.
Mukhopadhya I; Murray GI; Berry S; Thomson J; Frank B; Gwozdz G; Ekeruche-Makinde J; Shattock R; Kelly C; Iannelli F; Pozzi G; El-Omar EM; Hold GL; Hijazi K
J Antimicrob Chemother; 2016 Feb; 71(2):372-86. PubMed ID: 26514157
[TBL] [Abstract][Full Text] [Related]
9. Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention.
Nicol MR; Fedoriw Y; Mathews M; Prince HM; Patterson KB; Geller E; Mollan K; Mathews S; Kroetz DL; Kashuba AD
J Clin Pharmacol; 2014 May; 54(5):574-83. PubMed ID: 24343710
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque.
Zhou T; Hu M; Pearlman A; Patton D; Rohan L
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1106-16. PubMed ID: 24803409
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.
Nuttall J; Kashuba A; Wang R; White N; Allen P; Roberts J; Romano J
Antimicrob Agents Chemother; 2012 Jan; 56(1):103-9. PubMed ID: 21986823
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial.
Keller MJ; Wood L; Billingsley JM; Ray LL; Goymer J; Sinclair S; McGinn AP; Marzinke MA; Frank B; Srinivasan S; Liu C; Atrio JM; Espinoza L; Mugo N; Spiegel HML; Anderson PL; Fredricks DN; Hendrix CW; Marrazzo J; Bosinger SE; Herold BC
Lancet HIV; 2019 Aug; 6(8):e498-e508. PubMed ID: 31320290
[TBL] [Abstract][Full Text] [Related]
14. In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of Colorectal HIV Transmission.
Swedrowska M; Jamshidi S; Kumar A; Kelly C; Rahman KM; Forbes B
Mol Pharm; 2017 Aug; 14(8):2660-2669. PubMed ID: 28648081
[TBL] [Abstract][Full Text] [Related]
15. Dual antiretroviral therapy with tenofovir (TDF) and darunavir/ritonavir (DRV/RTV) in an HIV-1 positive patient: a case report, review, and meta-analysis of the literature on dual treatment strategies using protease inhibitors in combination with an NRTI.
Höring S; Löffler B; Pletz MW; Rößler S; Weis S; Schleenvoigt BT
Infection; 2018 Oct; 46(5):599-605. PubMed ID: 29961209
[TBL] [Abstract][Full Text] [Related]
16. Vaginal expression of efflux transporters and the potential impact on the disposition of microbicides in vitro and in rabbits.
Grammen C; Baes M; Haenen S; Verguts J; Augustyns K; Zydowsky T; La Colla P; Augustijns P; Brouwers J
Mol Pharm; 2014 Dec; 11(12):4405-14. PubMed ID: 25327902
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral Drug Concentrations in Lymph Nodes: A Cross-Species Comparison of the Effect of Drug Transporter Expression, Viral Infection, and Sex in Humanized Mice, Nonhuman Primates, and Humans.
Burgunder E; Fallon JK; White N; Schauer AP; Sykes C; Remling-Mulder L; Kovarova M; Adamson L; Luciw P; Garcia JV; Akkina R; Smith PC; Kashuba ADM
J Pharmacol Exp Ther; 2019 Sep; 370(3):360-368. PubMed ID: 31235531
[TBL] [Abstract][Full Text] [Related]
18. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK
J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.
Cunha-Reis C; Machado A; Barreiros L; Araújo F; Nunes R; Seabra V; Ferreira D; Segundo MA; Sarmento B; das Neves J
J Control Release; 2016 Dec; 243():43-53. PubMed ID: 27664327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
